EPS Creative Health Technology Group (HKSE:03860) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03860 EPS Creative Health Technology Group Ltd HKSE:03860
56 GF Score
Price HK$0.63
GF Value HK$0.59
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is EPS Creative Health Technology Group FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:03860
56GF Score
EPS Creative Health Technology Group Ltd HKSE:03860
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is EPS Creative Health Technology Group (HKSE:03860) Overvalued in 2026?

Based on GuruFocus' analysis, EPS Creative Health Technology Group stock appears to be overvalued. The current stock price of HK$0.63 is trading 6.8% above its estimated GF Value™ of HK$0.59. GuruFocus considers EPS Creative Health Technology Group to be Fairly Valued.

Key valuation signals for HKSE:03860:

  • FFO:
  • GF Value™: HK$0.59 vs. price of HK$0.63 (6.8% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the HKSE:03860 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EPS Creative Health Technology Group Business Description

Address 23 Man Lok Street, Flat A, 17th Floor, Grandview Tower, Hung Hom, Kowloon, Hong Kong, HKG
EPS Creative Health Technology Group Ltd is an investment holding company. Its segment includes the Garment business, Healthcare Products Business, and IRO with CRO and In-House R&D Business. It generates maximum revenue from the Garment segment which includes the provision of apparel supply chain management services for knitwear apparel products. Geographically, it derives a majority of revenue from Japan and also has its presence in Hong Kong, Mainland China, Europe, United States and Other Countries.
56GF Score

Get the complete analysis for HKSE:03860

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.63
Price
HK$0.59
GF Value